DIRS.INFO The most relevant business & tech news

☆ Merck beats quarterly sales estimate on top drugs' strength
▼ + stars: | 2023-08-01 | by ( Michael Erman | ) www.reuters.com time to read: +3 min

Companies Merck & Co Inc FollowAug 1 (Reuters) - Merck & Co (MRK.N) posted better-than-expected second-quarter sales on Tuesday on strong demand for its two top-selling products, cancer immunotherapy Keytruda and human papillomavirus (HPV) vaccine Gardasil. Shares of Merck rose about 2% at $108.45 in premarket trading after the company also raised its full-year revenue forecast. Merck said Keytruda sales for the quarter jumped 19% to $6.3 billion, surpassing analysts' average estimate of $5.9 billion. Sales of Gardasil, which prevents cancers caused by HPV, surged 47% to $2.5 billion, also well above Wall Street estimates of $2.1 billion. Merck said it now expects full-year sales of $58.6 to $59.6 billion, up from its prior view of $57.7 billion to $58.9 billion.

Persons: Merck, Rob Davis, Davis, Keytruda, Cantor Fitzgerald, Louise Chen, Prometheus, drugmaker, Michael Erman, Leroy Leo, Bill Berkrot Organizations: Merck, Co, Merck & Co, Merck's, Prometheus Biosciences, Analysts, Prometheus, Thomson Locations: United States, China, U.S, New York, Bengaluru

☆ Apps Like Dipsea and Quinn are Redefining Pleasure for Women
▼ + stars: | 2023-07-31 | by ( Sarah Diamond | ) www.nytimes.com time to read: +10 min

AudioStories AreRedefiningPleasure forWomen Apps like Dipsea and Quinn have become popular destinations, particularly for some women who find them safe spaces to explore their sexuality. On average, subscribers for Dipsea are women between 18 and 34, the company said, while Quinn’s are women ages 18 to 24. I s w a l l o w e d a s m a l l m o a n . ” “ H m , c o m e h e r e t h e n . ” “ G e t i t o u t o f o u r s y s t e m s .

Persons: Quinn, Liz, Sevyn, Dipsea, Bloom, ”, Caroline Spiegel, Evan, “, ” Ms, Spiegel, Hannah Albertshauser, Michael, Albertshauser, you’re, Mal Harrison, Dominnique Karetsos, Karetsos, Dame, Gina Gutierrez, Faye Keegan, ” ‘ It’s, Liv Trexler, it’s, Trexler, “ It’s, ” Angela Sarakan, ” Olivia Taylor, that’s, ’, Ms, Taylor, Aisha Jordan, Jordan, Nicole Prause, Prause, Lone Wolf, Shannon Lin Organizations: Facebook, Center for Erotic Intelligence, Healthy, Group, Getty Images Locations: California, Germany, Brooklyn

☆ Jaden Smith says he took magic mushrooms as a young adult. Brain experts who study psychedelics warn that wasn't a good idea.
▼ + stars: | 2023-07-29 | by ( Adam Barnes | ) www.businessinsider.com time to read: +9 min

Jaden Smith said his mother, Jada Pinkett Smith, introduced him to magic mushrooms. Jaden Smith recently discussed his introduction to psychedelic mushrooms by his mother, Jada Pinkett Smith — who has credited mushrooms as helping her overcome crippling depression. (L-R) Jaden Smith, Jada Pinkett Smith, and Will Smith. Trey Smith, Willow Smith, Jaden Smith, Will Smith, and Jada Pinkett Smith at the premiere of Apple Original Films' "Emancipation" on November 30, 2022. There are too many unknowns and too much to lose with a developing brain," psychiatrist and neurobiologist Dr. David Feifel told Insider.

Persons: Jaden Smith, Jada Pinkett Smith, Jada Pinkett Smith —, Jaden, Smith, Dustin Hines, Rochelle Hines, Will Smith, Amy Sussman, WireImage, —, Trey Smith, Willow Smith, Hines, it's, psychedelics, Dr, David Feifel, Feifel, haven't Organizations: Service, psychedelics, University of Nevada Las, Hines, National Survey, FDA, Apple Locations: Wall, Silicon, Denver

☆ Fighting With Your Partner? Use These 4 Phrases.
▼ + stars: | 2023-07-28 | by ( Jancee Dunn | More About Jancee Dunn | ) www.nytimes.com time to read: +1 min

Making these assumptions can escalate an argument and distort the issue, Real said. When you find yourself in a storytelling spiral, pause and remind yourself that you care about the person who has upset you, Real said. “Share only the facts — ones a camera could record,” he said. The key to this statement, and the feedback wheel overall, is its brevity, Real said. “The stories we tell ourselves are informed by our internal landscape of wounds and tender spots and traumas and patterns,” she said.

Persons: Real, Janet Hurley —, ”, Alexandra Solomon, “, It’s, ” Real Organizations: Northwestern University

☆ AstraZeneca to buy Pfizer's rare disease gene therapy portfolio for up to $1 bln
▼ + stars: | 2023-07-28 | by ( ) www.reuters.com time to read: +1 min

[1/2] FILE PHOTO-Test tubes are seen in front of a displayed AstraZeneca logo in this illustration taken, May 21, 2021. REUTERS/Dado Ruvic/Illustration/File PhotoJuly 28 (Reuters) - AstraZeneca (AZN.L) said on Friday its unit Alexion has agreed to buy U.S. drugmaker Pfizer's <PFE.N> early-stage rare disease gene therapy portfolio for up to $1 billion, plus royalties on sales. AstraZeneca bought Alexion in 2021. It focuses on rare diseases and plans to close the deal in the third quarter, the British drugmaker said. AAV capsids have been shown to be an effective mechanism for delivering therapeutic gene cargos for gene therapy and gene editing, the company said.

Persons: Dado Ruvic, Alexion, drugmaker, AAV, Yadarisa, Nivedita Organizations: AstraZeneca, REUTERS, Thomson Locations: Bengaluru

☆ Weight loss drug Wegovy is from Europe — but users in the region face a long and costly wait
▼ + stars: | 2023-07-26 | by ( Karen Gilchrist | ) www.cnbc.com time to read: +3 min

Packages of the weight-loss drug Wegovy from the pharmaceutical company Novo Nordisk lie on the sales counter in a Danish pharmacy. Still, it's seen as too expensive for many public health systems in Europe. They're obviously in a capacity constrained environment and we don't know how much they're willing to allocate to Europe. Eli Lily , whose diabetes drug Mounjaro can also be used for weight loss, has also faced supply gluts. They're obviously in a capacity constrained environment and we don't know how much they're willing to allocate to Europe," Field said.

Persons: Stefan Trumpf, it's, Emily Field, Wegovy's, Eli Lily Organizations: Novo Nordisk, Getty, CNBC, Denmark — Novo, Barclays, BMI, German Obesity Society, Novo Nordisk — Locations: Danish, Germany, Europe, Denmark, Norway, Novo, U.S

☆ They took blockbuster drugs for weight loss and diabetes. Now their stomachs are paralyzed
▼ + stars: | 2023-07-25 | by ( Brenda Goodman | ) edition.cnn.com time to read: +19 min

Emily Wright, 38, a teacher in Toronto, started taking Ozempic in 2018. The diabetes drug Ozempic, and its sister drug for weight loss, Wegovy, utilize the same medication, semaglutide. Gastroparesis can have many causes, including diabetes, which is a reason many people are on these drugs in the first place. In more than half of cases of gastroparesis, doctors are unable to find a cause. Until more is known, George said, people need to be open with all their doctors about taking any drugs.

Persons: Joanie Knight, “, I’d, ”, Knight, ” Brenda Allen, I’m, ” Allen, Emily Wright, she’s, Wright, “ I’ve, ” Wright, Ozempic, Emily Wright Allen doesn’t, they’ve, Gastroparesis, Michael Camilleri, Camilleri, liraglutide, ” Camilleri, ’ Joanie Knight, it’s, —, I’ve, let’s, ’ ” Wright, gastroparesis, ” Knight, we’re, there’s, gastroparesis weren’t, “ Gastroparesis, Linda Nguyen, Nguyen, Renuka George, George, ” George, Dr, Michael Champeau, ” Champeau, Sanjay Gupta Organizations: CNN, US Food and Drug Administration, American Society of Anesthesiologists, Novo Nordisk, Mayo Clinic, National Institutes of Health, Diabetes, ”, FDA, Stanford University, American Gastroenterological Association, Medical University of South, CNN Health, Stanford Locations: Angie , Louisiana, Dallas, Toronto, Medical University of South Carolina, Louisiana

☆ Toms Shoes Founder Blake Mycoskie talks the therapeutic benefits of psychedelics
▼ + stars: | 2023-07-21 | by ( ) www.cnbc.com time to read: 1 min

Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailToms Shoes Founder Blake Mycoskie talks the therapeutic benefits of psychedelicsToms Shoes Founder Blake Mycoskie joins “Last Call” to talk the use of psychedelics for therapeutic purposes.

Persons: Toms, Blake Mycoskie, psychedelics Toms

☆ Lisa Marie Presley died of small bowel obstruction - coroner
▼ + stars: | 2023-07-14 | by ( ) www.reuters.com time to read: +2 min

July 13 (Reuters) - Lisa Marie Presley, the only daughter of Elvis Presley, died of a small bowel obstruction as a delayed consequence of bariatric weight loss surgery, the Los Angeles County Medical Examiner reported on Friday, six months after she died. Presley, a singer and songwriter in her own right, had been taken to hospital after reportedly suffering cardiac arrest at her home. The medical examiner listed the cause of death as "sequelae of small bowel obstruction." "The obstruction was in the form of a strangulated small bowel caused by adhesions that developed after bariatric surgery years ago," the examiner said in a report. She was the only child of one of the greatest stars in American music, and was 9 years old when Elvis Presley died of heart failure at age 42 in 1977 at Graceland.

Persons: Lisa Marie Presley, Elvis Presley, Presley, Priscilla Presley, Austin Butler, Riley Keough, Finley, Harper Lockwood, Michael Jackson, Nicholas Cage, Daniel Trotta, Robert Birsel Organizations: Los Angeles, Medical, Golden Globe, Thomson Locations: Beverly Hills , California, Graceland

☆ Lisa Marie Presley died of small bowel obstruction, coroner says
▼ + stars: | 2023-07-14 | by ( ) www.reuters.com time to read: +2 min

CNN —The US Food and Drug Administration is expected to decide on Thursday whether to grant traditional approval to the Alzheimer’s drug Leqembi, the first medicine proven to slow the course of the memory-robbing disease. Leqembi, from drugmakers Eisai and Biogen, received accelerated approval in January based on evidence that it clears amyloid plaque buildups in the brain that are associated with Alzheimer’s disease. But because of an earlier coverage decision by CMS, which provides insurance coverage for many elderly patients with Alzheimer’s through Medicare, the drug hasn’t been widely used. People with more advanced forms of the disease may not benefit from the drug, he said, and may face increased safety risks. Broad Medicare coverage of Leqembi and similar types of medications to slow the progression of Alzheimer’s disease would probably have a big impact on the program’s spending.

Persons: drugmakers, hasn’t, “, ’ ”, Joe Montminy, Lawrence Honig, “ It’s, ”, Honig, it’s, Leqembi, ” Honig, Georges Naasan, Sue Rottura, ” Drugmaker Eisai, “ You’re, Ivan Cheung, Eisai, ” Montminy, Dr, Sanjay Gupta Organizations: CNN, Food and Drug Administration, Medicare, Services, CMS, Columbia University Irving Medical Center, Alzheimer’s, Behavioral, CNN Health, Kaiser Family Foundation Locations: Mount, Florida

☆ Australia ushers in a new era of psychedelic medicine
▼ + stars: | 2023-06-30 | by ( Katie Hunt | ) edition.cnn.com time to read: +8 min

Australia may be the first country to regulate the therapeutic use of MDMA and psilocybin, but it isn’t alone in ushering in a new era of psychedelic medicine. In October 2022, Alberta became the first jurisdiction in Canada to regulate the use of psychedelic drugs. Combining psychotherapy with psychedelic drugs is thought to be necessary for a beneficial outcome. He said that psychedelic drugs resulted in “powerful altered states of consciousness that can be intensely therapeutic, but also intensely destabilizing. “If you have a regulated, insured, safe context, and a good psychotherapeutic relationship, and yes, there’s the potential for great benefit there.”However, Rucker stressed that psychedelic drugs were not “a chemical switch to make everything seem fine.

Persons: ”, haven’t, Colleen Loo, Loo, “, Cole Burston, Celia Morgan, Morgan, James Rucker, “ You’re, ” Morgan, ” Rucker, prescriber, Rucker Organizations: CNN, Goods Administration, US Food and Drug Administration, University of New, Black Dog Institute, The Royal, New Zealand College of Psychiatrists, Oregon Health Authority, Getty, University of Exeter, The New England, of Medicine, of Psychiatry, Neuroscience, King’s College London, Therapeutic Goods Locations: Australia, University of New South Wales, Sydney, RANZCP, Alberta, Canada, AFP, United Kingdom, The, psychopharmacology

☆ A portfolio manager at a $179 billion asset manager breaks down how he picks stocks that can endure a volatile economy — and shares 6 of his favorite names to buy
▼ + stars: | 2023-06-30 | by ( Lisa Kailai Han | ) www.businessinsider.com time to read: +6 min

Portfolio manager Elias Erickson focuses on finding stocks that can withstand market fluctuations. With the bull market still flourishing, current stock market conditions are a far cry from where they began the year. Coming off last October's market lows, a series of macroeconomic factors have given equities plenty of whiplash this year. "We're trying to buy businesses that will be adaptable to a variety of different macroeconomic environments," Erickson explained to Insider in an interview. Constellation Software, a Canadian-based acquirer of vertical market software, also makes up one of Erickson's largest positions.

Persons: Elias Erickson, Roger Altman, Paul Krugman, Elias Erickson isn't, Erickson, That's, Hermès, they've, Sartorius Organizations: SAP, Constellation Software, Constellation, Mastercard Locations: Canadian, Lonza

Georgetown University in Washington, D.C. Not everyone with debt would have been covered under the Biden administration’s student loan forgiveness plan. The Supreme Court has barred the Biden administration from carrying out its plan to extinguish up to $20,000 in federal student loan debt, and millions of borrowers will continue to struggle under the weight of their loans. Ms. Schmidt owes $64,000 in student debt, more than half of which is for her graduate work in nursing. But she’s already contemplating how she’ll finance her dream of becoming a civil rights lawyer, which typically requires an additional six figures in student debt. Yet her mother is still paying down student debt of her own.

Persons: Biden, Gina McDavitt, weren’t, Pell, “, ”, McDavitt, ” Ms, Ms, Monica Schmidt, Schmidt, Kevin Serna, Dorien Rogers, Rogers, Asha Anthony, she’s, —, Anthony, Mr, don’t, Joanna Leiserson, Brian Kaiser, “ I’m, Leiserson Organizations: Georgetown University, Biden, College of San, San Francisco State University, The New York Times, University of Phoenix, Northern Illinois University, Public, Schaun, Tax, Howard University, Salisbury University, The New York, Republicans Locations: Washington ,, College of San Mateo, Bay, Vallejo , Calif, Genoa, Ill, Germantown, Md, Credit, Montgomery County, Mesa, Maryland, Spokane, —, forbearance

☆ Bayer claims early lead in Parkinson's stem cell therapy
▼ + stars: | 2023-06-28 | by ( Ludwig Burger | ) www.reuters.com time to read: +3 min

Some of this work is done by Britain's' Cambridge University, South Korea's Bundang CHA Hospital, International Stem Cell Corp's (ISCO.PK) Cyto Therapeutics in Australia, the Chinese Academy of Sciences, Harvard University and Japan's Kyoto University Hospital. For BlueRock's experimental therapy, researchers took induced pluripotent stem cells, which are modified to regain the ability to form any type of specialised tissue, and transformed them into dopamine-producing nerve cells. When surgically implanted into the brain of a person with Parkinson's disease, the therapeutic cells are designed to restore neural networks destroyed by the disease. Initial trial results showed the cells multiplied and started making dopamine, an important brain signalling molecule which is lacking in Parkinson's patients. Parkinson's, for which there is no cure and which affects more than 10 million people worldwide, causes progressive brain damage.

Persons: Wolfgang Rattay, Bayer, BlueRock, Britain's, Jennifer Doudna, Ludwig Burger, Miranda Murray, Mark Potter Organizations: Bayer AG, REUTERS, Bayer, Cambridge University, South Korea's, CHA Hospital, Cyto Therapeutics, Chinese Academy of Sciences, Harvard University, Japan's Kyoto University Hospital, BlueRock Therapeutics, Mammoth Biosciences, Thomson Locations: Leverkusen, Germany, FRANKFURT, Australia, San Francisco Bay

☆ Pfizer to end development of experimental obesity pill due to elevated liver enzymes
▼ + stars: | 2023-06-26 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +3 min

Pfizer on Monday said it would stop developing its experimental obesity and diabetes pill, lotiglipron, due to elevated liver enzymes in patients who took the drug once a day in mid-stage clinical studies. New York-based Pfizer said it will instead focus on its other oral obesity drug, danuglipron, which is in a fully enrolled phase two clinical trial. Pfizer CEO Albert Bourla has said that an obesity pill could eventually generate $10 billion each year for the company. The new class of obesity drugs is piquing public interest and causing a weight loss industry gold rush. Analysts believe Eli Lilly’s pill has an edge over Pfizer’s danuglipron.

Persons: William Sessa, Albert Bourla, Eli Lilly, Eli Lilly’s, danuglipron, Wells, Mohit Bansal, orforglipron, Bansal Organizations: Pfizer, Novo Nordisk, National Institutes of Health Locations: New York, danuglipron

☆ How a Recycling Leader Spends His Sundays
▼ + stars: | 2023-06-25 | by ( Alix Strauss | ) www.nytimes.com time to read: +1 min

PROCESS We meet in the back room of the Revision Lounge, a bar in the East Village, where one of the members works. As a theater company, we’re still learning what life after the pandemic is like. POOR PLAYERS We usually break out our scripts and refine what we’ve done or are transforming. Our next play is Macbeth, which we perform at various places, the bar, Sure We Can, or at people’s homes. Every actor learns the complete text of the play and we change roles on impulse so it’s constantly shifting.

Persons: we’re, it’s, They’re Locations: East

☆ Aaron Rodgers: NFL star credits psychedelics for improving his performance on the football field
▼ + stars: | 2023-06-23 | by ( George Ramsay | ) edition.cnn.com time to read: +3 min

CNN —Aaron Rodgers has continued to advocate for the legalization of some psychedelics, claiming this week that ayahuasca helped to improve his performance on the football field. The NFL has confirmed that taking ayahuasca doesn’t violate its drug policy. CNN has reached out to the NFL about psilocybin and its drug policy. Rodgers, who recently left the Packers for the New York Jets, made reference to the decriminalization of psilocybin in Colorado while speaking in Denver. “The response from other people in the sports industry has been pretty incredible,” said Rodgers.

Persons: CNN — Aaron Rodgers, ayahuasca, It’s, ” Rodgers, “, Rodgers, Matthew Stockman, Aubrey Marcus, they’ve, ” Organizations: CNN, NFL, Green Bay Packers, Oregon, Packers, New York Jets, Getty Locations: Denver , Colorado, Colorado, Denver, psychedelics

☆ This German drug stock can rally more than 40% thanks to its A.I. potential, Morgan Stanley says
▼ + stars: | 2023-06-23 | by ( Brian Evans | ) www.cnbc.com time to read: +2 min

Morgan Stanley thinks little-known drug developer Evotec could benefit from artificial intelligence advancements in Europe and new collaborations with peer companies. EVO YTD mountain Evotec SE stock has surged 40% from the start of the year. Meanwhile, a security breach in April did little to caution Quigley away from the stock. The analyst highlighted the company's potential to better use AI to aid in drug development in the future, as well as partnerships with big pharma names. "A number of Pharma companies are investing in internal AI/ML efforts," he added.

Persons: Morgan Stanley, Morgan Stanley's, James Quigley, Quigley, Evotec, Eli Lilly, — CNBC's Michael Bloom Organizations: pharma, Merck & Co, Bristol Myers Squibb, Novo Nordisk Locations: Europe, Germany

☆ California, other states join FTC bid to block Amgen deal
▼ + stars: | 2023-06-22 | by ( David Shepardson | ) www.reuters.com time to read: +2 min

WASHINGTON, June 22 (Reuters) - The states of California, New York, Illinois, Minnesota, Washington and Wisconsin have joined a Federal Trade Commission (FTC) lawsuit to stop Amgen's (AMGN.O) $27.8 billion deal to buy Horizon Therapeutics (HZNP.O), according to a court filing on Thursday. Washington Attorney General Bob Ferguson said his state had joined the lawsuit because "monopolies harm consumers" and the merger could allow Amgen to "dominate" prescription drug markets. The FTC acquisition marks a change for the agency, which previously had typically flagged therapeutic overlaps in companies and waved deals through after requiring one of the medicines to be divested. Amgen said in a statement last month it was disappointed by the FTC decision and it believed it had "overwhelmingly demonstrated" that the deal had no legitimate competitive issues. The last major pharmaceutical deal approved by the FTC was AstraZeneca's (AZN.L) $39 billion acquisition of Alexion Pharma in April 2021, about two months before FTC Chair Lina Khan was appointed by the Biden administration.

Persons: Bob Ferguson, Rob Bonta, Amgen, Lina Khan, Biden, David Shepardson, Jamie Freed Organizations: Federal Trade Commission, Horizon Therapeutics, . Washington, FTC, Horizon, Alexion Pharma, Thomson Locations: California , New York , Illinois, Minnesota, Washington, Wisconsin, California

☆ The Africans fighting on Russia’s front line in Ukraine
▼ + stars: | 2023-06-22 | by ( ) www.reuters.com time to read: +18 min

In journeying to Russia, Tarimo was following the route of many young Africans, including future heads of state, since the 1960s. Tarimo also ended up treading the path of a handful of other Africans who took up arms for Wagner in Ukraine. The presidents of South Africa and Zambia are now among a group of African leaders seeking to mediate between Russia and Ukraine. In November last year, his family learned he too had died in Ukraine fighting for Wagner. He said that, like Tarimo, Nyirenda cast his desire to join Wagner as repayment for Soviet and Russian support of African anti-colonial movements.

Persons: Russian Wagner, Nemes, Wagner, ”, Tarimo, “ Nemes, Rehema Kigobe, – Tarimo, Aboya, Claire Amuhaya, Nemes Tarimo, Rehema, “, Vladimir Putin, Chadema, Alexander Shilkin, ” Wagner, Yevgeny Prigozhin, Kristian Malundama, Malundama, Tarimo’s, Prigozhin, Lemekani, Christian, didn’t, Will, Nyirenda, Ronald Kalifungwa, Zikonde, –, …, “ I’m, Christopher Kangwa, Tionge, ” Nyirenda, ” Kangwa, Fabrice Organizations: Moscow’s Pushkin Institute, Russian Technological University, Reuters, Friendship University, Soviet Union, National Congress, European Union, United Nations General Assembly, Wagner Group, Central African Republic, Officials, Dar es Salaam, Democratic, Tanzanian, Zambian, Instagram, Research Nuclear University, Baptist, YouTube, ” Reuters, Ivorian Locations: Russian, Ukrainian, Bakhmut, Dar es, Tanzania’s, Odradivka, Moscow, IT, Russia, Ukraine, Zambian, Ivory Coast, Soviet, Kenyan, Africa, United States, South Africa, Zambia, Mali, Libya, Central, Tanzania, kwa, Sochi, Tanzanian, Tarimo’s, Yaroslavl region’s, Rybinsk, Democratic Republic of Congo, Yaroslavl, Ukraine’s, Lusaka’s Northmead, China, Lemekani, Tver region’s, Tver’s, Russia’s, Mordovia, Yopougon, Abidjan, Ivory Coast’s, Cocody

☆ Cloning Scientist Hwang Woo-suk Gets a Second Chance. Should He? - The New York Times
▼ + stars: | 2023-06-21 | by ( David Cyranoski | ) www.nytimes.com time to read: +1 min

Science is known for rigorous self-policing by the research community, yet it can feel like scientific fraud is rampant. The story of Hwang Woo-suk, a South Korean scientist who gained notoriety for claiming to clone human embryos, provides clues. After leaving the field in disgrace, Dr. Hwang has landed in clover, and now spends his days cloning beauty show and racing camels for United Arab Emirates royalty. Dr. Hwang burst into the spotlight in 2004 when he reported success in making an embryonic human clone and deriving stem cells from it. This was the proof-of-principle for the once-hyped “therapeutic cloning” — in which patients’ own cells, from the skin or other tissue, could be used to create embryonic stem cells with their genetic signature, which could then be used to treat diseases.

Persons: Hwang Woo, suk, Hwang Organizations: South, United Arab, Netflix, YouTube Locations: South Korean, United Arab Emirates

☆ This stock could become a 'one-stop shop' for biopharma and rally more than 35%, RBC says
▼ + stars: | 2023-06-21 | by ( Alex Harring | ) www.cnbc.com time to read: +2 min

Avantor can show near-term resilience before outperforming in the long term, according to RBC Capital Markets. Analyst Conor McNamara initiated coverage of the health care products stock at outperform. His $27 price target implies a 37.4% upside from where shares finished Tuesday. AVTR YTD mountain Avantor Avantor is well-positioned for the long-term, McNamara said, as the life science tools sector is one of the most attractive in health care. Though the price target would require the stock to trade at historical multiples relative to peers, McNamara said that would be justified after the company's operating improvements in recent years.

Persons: Conor McNamara, McNamara, — CNBC's Michael Bloom Organizations: RBC Capital Markets

☆ Eli Lilly to acquire Dice Therapeutics for $2.4 billion in autoimmune treatment push
▼ + stars: | 2023-06-20 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +1 min

Eli Lilly on Tuesday said it struck a $2.4 billion deal to acquire Dice Therapeutics in a bid to bulk up its treatment portfolio for immune-related diseases. Dice Therapeutics' share price jumped more than 37% to just under the purchase price. Auto-immune diseases can causes pain, fatigue, dizziness, depression and rashes, among other symptoms. There are more than 100 known autoimmune diseases, including lupus, rheumatoid arthritis, Crohn's disease and ulcerative colitis. Eli Lilly's immunology portfolio includes drugs like Taltz, which treats plaque psoriasis, and Olumiant, a treatment for rheumatoid arthritis.

Persons: Eli Lilly, Eli Lilly's, Patrik Jonsson, Eli, Taltz Organizations: Dice Therapeutics Locations: Francisco

☆ These medical device makers are driving a 'paradigm' shift in cardiac care, Piper Sandler says
▼ + stars: | 2023-06-19 | by ( Christina Cheddar Berk | ) www.cnbc.com time to read: +3 min

A safer, quicker way to treat some heart arrhythmia cases could be on the horizon, creating an opportunity for medical device companies Boston Scientific and Medtronic, according to Piper Sandler analyst Matt O'Brien. He estimates that Boston Scientific will ring up $454 million in sales by 2025 for its Farapulse catheter. Meanwhile, Boston Scientific shares hit a record high on Friday. BSX YTD mountain Boston Scientific shares have gained more than 17% so far this year. He expects that this could prompt consolidation, providing a way for any larger AF treatment providers that have fallen behind on innovation to catch up.

Persons: Piper Sandler, Matt O'Brien, O'Brien, Medtronic, Medtronic's, Abbott, Johnson Organizations: Boston Scientific, Centers for Disease Control, PFA, Boston, EU Locations: U.S

Search resuls for: "Therapeutic"

25 mentions found